Housing Conditions: Evaluation, Advocacy and Research in Toronto Community Housing (HEARTH)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5B1W8
- St. Michael's Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years or older
- Living in one of the three TCHC buildings
Exclusion Criteria:
- under 18 years old
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Community Organizing
All tenants in three TCHC buildings will be invited to participate in a survey on their building conditions at baseline, 6 months and 12 months.
Once baseline data collection is complete, there will be a community organizing campaign involving tenants to advocate for improved building conditions.
|
The intervention will be community organizing and will consist of engaging tenants, health providers, legal service staff, social service agencies and advocacy organizations (e.g.
ACORN).
Each building team will identify initial priorities and then invite all building members to discuss and to finalize, as well as a plan for change.
Building teams will engage in advocacy to TCHC and its representatives, and other city departments as appropriate.
Engaging in advocacy will consist of a wide range of activities but essentially means presenting evidence (e.g.
personal experiences, data) to policymakers and decision makers to affect change.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tenant engagement in intervention
Time Frame: 12 months
|
Acceptability and feasibility of the intervention, assessed through qualitative focus groups with participants in each intervention building.
The HEARTH Survey was built by the research team (example question: How satisfied are you with the condition of your building?).
All qualitative data will be managed and analyzed with the data management software, NVivo.
|
12 months
|
|
Building conditions
Time Frame: 12 months
|
Change in the state of housing evaluated by a questionnaire completed by tenants and official reports from the Toronto Community Housing Corporation.
The HEARTH survey consisted of various questions relating to this, leading to different answers due to different scales.
For example, for safety of the building, the options were: very safe, fairly safe, neither safe nor unsafe, fairly unsafe, and very unsafe.
All scales had 5 options/outcomes but different wordings.
No quantitative score was used for this.
|
12 months
|
|
Health (Patient-Reported Outcomes Measurement Information System (PROMIS) scale)
Time Frame: 12 months
|
Change in self-rated physical and mental health, sense of security, social integration, evaluated by surveys of residents using PROMIS scale.
This scale is validated.
For pain, the minimum score is 0 and the maximum score is 10, with 10 representing the worst pain imaginable.
The higher the number on the scale, the worse the outcome/issue is.
|
12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Andrew Pinto, MSc MD, Unity Health Toronto
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- SMH-18-154
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.